SEARCH RESULTS FOR: (*cloud mining with parvez馃挷itenthusiasts.com馃挷Crypto*)(3464 results)
WELLlife™ COVID-19/Influenza A&B Home Test Cassette, 2 Tests per Kitbox with Holder; SD
WONDFO USA CO., LTD.
WV01P0001-2S
In Commercial Distribution
- 10816862026150 ()
- 00816862026153 ()
- 00816862026146 ()
- SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing
App for controlling Biomeme Frankin three9 thermocycler when used with the Biomeme Real-Time RT-PCR SARS-CoV-2 Test
Biomeme, Inc.
2.3.5
In Commercial Distribution
- 00810096640130 ()
- SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
Control swabs intended for use only with BinaxNOW COVID-19 Ag product manufactured by Abbott Diagnostics Scarborough, Inc.
Alere Scarborough, Inc.
195-080
In Commercial Distribution
- 10811877011306 ()
- SARS-CoV-2 antigen IVD, control
Walgreens Motion Sickness Glasses 1CT -
Walgreens Motion Sickness Glasses help alleviate symptoms associated with motion sickness based on the theory of synchronizing your visual system with the motion of the vehicle. The level of blue liquid in the glasses varies according to motion, creating an artificial horizon in your vision to help re-synchronize your eyes with your sense of balance. These motion sickness glasses are drug free and are suitable for both adults and children.
WALGREEN CO.
486529
In Commercial Distribution
- 00311917123738 ()
- 10311917123735 ()
- Spectacle frame
Tubes filled with 3mL aliquots of Biomemes DNA/RNA Preservation buffer for sample collection, storage, and preservation at room temperature. Pack of 100 pre-filled tubes.
Biomeme, Inc.
1
In Commercial Distribution
- 10810096640106 ()
- 00810096640109 ()
3000577
- SARS-CoV-2 nucleic acid IVD, kit, nucleic acid technique (NAT)
The Rapid SARS-CoV-2 Antigen Test Card is a single use rapid lateral flow chromatographic immunoassay intended for the qualitative detection of nucleocapsid protein antigen from SARS-CoV-2. This test is authorized for non-prescription home use with self-collected anterior nasal (nares) swab samples from individuals aged 14 and older, when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.
This test is also authorized for non-prescription home use with adult-collected anterior nasal (nares) swab samples from individuals aged 2 years and older when tested twice over three days with at least 24 hours (and no more than 48 hours) between tests. The test is authorized for individuals aged 2 years and older with symptoms of COVID-19 within the first 6 days of symptom onset, or individuals without symptoms or other epidemiological reasons to suspect COVID-19.
LUMIQUICK DIAGNOSTICS, INC.
1N40C5-1-US-BS
In Commercial Distribution
- 00855636003723 ()
- 00855636003716 ()
- 00855636003730 ()
- 00855636003747 ()
- 00855636003754 ()
- 00855636003761 ()
- 00855636003778 ()
- 00855636003785 ()
1N40C5-1-US-BS
- SARS-CoV-2 antigen IVD, kit, rapid ICT, clinical
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 5 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests. For use under an emergency use authorization (EUA) only.
Genbody Inc.
COVAGHT2-U-1
In Commercial Distribution
- 08800076700734 ()
COVAGHT2-U-01
- SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 5 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests. For use under an emergency use authorization (EUA) only.
Genbody Inc.
COVAGHT2-U-5
In Commercial Distribution
- 08800076700758 ()
- 08800076700727 ()
COVAGHT2-U-05
- SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 5 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests. For use under an emergency use authorization (EUA) only.
Genbody Inc.
COVAGHT2-U-25
In Commercial Distribution
- 08800076700765 ()
- 08800076700598 ()
COVAGHT2-U-25
- SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing
Non-prescription home use for the qualitative detection of nucleocapsid protein antigen from the SARS-CoV-2 virus with self-collected anterior nasal (nares) swab samples from individuals aged 14 years or older or adult collected anterior nasal (nares) swab samples from individuals aged 2 years or older. This test is authorized for individuals with symptoms of COVID-19 within the first 5 days of symptom onset when tested at least twice over three days with at least 48 hours between tests, and for individuals without symptoms or other epidemiological reasons to suspect COVID-19, when tested at least three times over five days with at least 48 hours between tests. For use under an emergency use authorization (EUA) only.
Genbody Inc.
COVAGHT2-U-2
In Commercial Distribution
- 08800076700741 ()
- 08800076700222 ()
COVAGHT2-U-02
- SARS-CoV-2 antigen IVD, kit, rapid ICT, self-testing